Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steward

Showing results (141-150 of 256) with videos related to

Pageof 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 12, 2010
Anthocyanin-rich red grape extract impedes adenoma development in the Apc(Min) mouse: pharmacodynamic changes and anthocyanin levels in the murine biophaseHong Cai, Timothy H Marczylo, Nicole Teller, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tractW P Steward, M Harris, J Wagstaff, et al.
British Journal of Cancer|May 1, 1990
Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancerW P Steward, J H Scarffe, L Y Dirix, et al.
British Journal of Cancer|November 1, 1994
Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescueD J Dunlop, E J Fitzsimons, A McMurray, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2008
Prognostic molecular markers in cholangiocarcinoma: a systematic reviewChristopher D Briggs, Christopher P Neal, Christopher D Mann, et al.
Molecular Cancer Therapeutics|September 20, 2005
The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin miceHong Cai, Mohammad Al-Fayez, Richard G Tunstall, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2008
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levelsRichard D Verschoyle, Peter Greaves, Ketan Patel, et al.
American Journal of Clinical Oncology|March 26, 2011
Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancerAli Arshad, Dhya Al-Leswas, Omer Al-Taan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2006
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignanciesR A Sharma, W P Steward, C A Daines, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivoStewart Sale, Isabel L Fong, Carla de Giovanni, et al.
Pageof 26

Showing results (141-150 of 256) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|January 12, 2010
Anthocyanin-rich red grape extract impedes adenoma development in the Apc(Min) mouse: pharmacodynamic changes and anthocyanin levels in the murine biophaseHong Cai, Timothy H Marczylo, Nicole Teller, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tractW P Steward, M Harris, J Wagstaff, et al.
British Journal of Cancer|May 1, 1990
Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancerW P Steward, J H Scarffe, L Y Dirix, et al.
British Journal of Cancer|November 1, 1994
Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescueD J Dunlop, E J Fitzsimons, A McMurray, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2008
Prognostic molecular markers in cholangiocarcinoma: a systematic reviewChristopher D Briggs, Christopher P Neal, Christopher D Mann, et al.
Molecular Cancer Therapeutics|September 20, 2005
The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin miceHong Cai, Mohammad Al-Fayez, Richard G Tunstall, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2008
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levelsRichard D Verschoyle, Peter Greaves, Ketan Patel, et al.
American Journal of Clinical Oncology|March 26, 2011
Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancerAli Arshad, Dhya Al-Leswas, Omer Al-Taan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2006
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignanciesR A Sharma, W P Steward, C A Daines, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivoStewart Sale, Isabel L Fong, Carla de Giovanni, et al.
Pageof 26